Verastem VSTM
NASDAQ VSTM
$7.91 -0.07 (-0.88%)
As of: Sep 4, 2026 · 1:36 PM EDT

Verastem (VSTM) Interest Expenses (2017 - 2026)

Verastem (VSTM) posted quarterly Interest Expenses of $855000.0 for Q1 2026, down 28.27% year-over-year from $1.2 million in Q1 2025, and up 106.02% quarter-over-quarter from $415000.0 in Q4 2025.

Analysis

Verastem (VSTM) Interest Expenses (2017 - 2026) Analysis & Trends

Verastem's Interest Expenses history runs 16 years deep, the most recent figure standing at $855000.0 for Q1 2026.

  • In Q1 2026, Interest Expenses fell 28.27% year-over-year to $855000.0; the TTM figure through Mar 2026 stood at $855000.0 (down 28.27% YoY), while the FY2025 annual figure was $6.4 million, up 39.5% from the prior year.
  • Interest Expenses for Q1 2026 stood at $855000.0, up from $415000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $11.0 million in Q2 2025, with the low at $257000.0 in Q1 2022.
  • The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $1.9 million.
  • The sharpest annual moves came in 2022 and 2025: Interest Expenses plunged 96.61% in 2022, then soared 867.4% in 2025.
  • Verastem's Interest Expenses stood at $724000.0 in 2022, then soared by 54.7% to $1.1 million in 2023, then climbed by 2.32% to $1.1 million in 2024, then slumped by 63.79% to $415000.0 in 2025, then surged by 106.02% to $855000.0 in 2026.
  • Business Quant data shows VSTM's Interest Expenses at $855000.0 in Q1 2026, $415000.0 in Q4 2025, and $4.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - 23.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 93.62 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 20.27 Mn
10 Verastem 789.92 Mn 653.56 Mn 36.32 Mn 360,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 360,000.00
Mar 31, 2026 382,000.00
Dec 31, 2025 415,000.00
Sep 30, 2025 319,000.00
Jun 30, 2025 212,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 1.15 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.13 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 1.13 Mn
Jun 30, 2023 1.12 Mn
Mar 31, 2023 769,000.00
Dec 31, 2022 724,000.00
Sep 30, 2022 717,000.00
Jun 30, 2022 640,000.00
Mar 31, 2022 56,000.00
Dec 31, 2021 10,000.00
Sep 30, 2021 7.98 Mn